查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1543674

全球重组化学品市场规模研究（依产品类型、技术、应用和区域预测 2022-2032）

Global Recombinant Chemicals Market Size Study, by Product Type, by Technology, by Application, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球重组化学品市场价值约为 29 亿美元，预计在 2024-2032 年预测期内将以超过 7.8% 的健康成长率成长。透过基因工程技术生产的重组化学物质包括重组蛋白、DNA 和胜肽。重组蛋白是由克隆基因产生的多肽，因其高纯度、特异性、高效、安全、客製化、可扩展性和一致性等优点而广泛应用于医学、研究和生物技术等领域。重组蛋白用于疫苗开发、治疗、诊断以及药物发现和开发。它们包括细胞激素、酵素、荷尔蒙、凝血因子、生长因子、单株抗体 (mAb) 和抗体相关产品。重组蛋白疫苗被认为比活病毒衍生的疫苗更安全，因为它们是非复製的并且缺乏传染性成分。

重组蛋白疫苗需求的成长正在显着推动重组化学品的市场价值。重组蛋白疫苗构成了一个经过验证且完善的疫苗开发平台，由于对基于重组蛋白的 SARS-CoV-2 疫苗的需求不断增加，其需求特别大，从而增加了对 DNA 衍生化学品的需求。遗传性疾病的流行也推动了重组化学品市场的发展。透过重组 DNA 技术生产的医药产品彻底改变了各种遗传性疾病的治疗和管理。重组化学品市场的主要参与者正在生产用于研究抗体和酵素结合位点的高纯度重组产品，以及新型小型疗法、药剂和疫苗。

重组 DNA 技术涉及连接两个不同物种的 DNA 分子，该技术在医药和生物技术产品（包括营养保健品）的生产中越来越受到关注。 Elelyso 等产品含有活性物质 taliglucerase alfa，采用重组 DNA 技术生产，用于治疗 1 型戈谢病等遗传性疾病。

全球重组化学品市场研究考虑的关键区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 2023年，北美将成为主导地区。这种主导地位主要是由先进的生物技术基础设施、研发方面的大量投资以及大型製药和生物技术公司的存在所推动的。此外，政府措施的大力支持和对生物製药的高需求也有助于北美在该市场的领先地位。另一方面，亚太地区是重组化学品成长最快的市场。该地区的快速成长得益于医疗保健支出的增加、生物技术产业的发展以及生命科学研究投资的增加。中国和印度等国家由于其不断扩大的製药业、有利的政府政策以及对精准医疗的日益关注而处于这一增长的前沿。此外，熟练劳动力的可用性和新生物技术新创公司的成立进一步加速了亚太地区的市场扩张。

目录

第 1 章：全球重组化学品市场执行摘要

  • 全球重组化学品市场规模及预测（2022-2032）
  • 区域概要
  • 分部摘要
    • 依产品类型
    • 依技术
    • 按申请
  • 主要趋势
  • 经济衰退的影响
  • 分析师推荐与结论

第 2 章：全球重组化学品市场定义与研究假设

  • 研究目的
  • 市场定义
  • 研究假设
    • 包含与排除
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（消费者的角度）
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者意识和接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第 3 章：全球重组化学品市场动态

  • 市场驱动因素
    • 对重组蛋白疫苗的需求增加
    • 遗传性疾病盛行率激增
  • 市场挑战
    • 经济不确定性和成本担忧
  • 市场机会
    • 重组 DNA 技术的创新
    • 应用领域的扩展

第 4 章：全球重组化学品市场产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
    • 波特五力模型的未来方法
    • 波特的五力影响分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章：全球重组化学品市场规模与预测：依产品类型 - 2022-2032

  • 细分仪表板
  • 全球重组化学品市场：2022 年和 2032 年产品类型收入趋势分析
    • 重组蛋白
    • 重组DNA
    • 重组胜肽
    • 其他的

第 6 章：全球重组化学品市场规模与预测：依技术分类 - 2022-2032

  • 细分仪表板
  • 全球重组化学品市场：2022 年和 2032 年技术收入趋势分析
    • 微生物表现系统
    • 哺乳动物细胞表现系统
    • 酵母表现系统
    • 昆虫细胞表现系统
    • 无细胞表现系统

第 7 章：全球重组化学品市场规模与预测：依应用分类 - 2022-2032

  • 细分仪表板
  • 全球重组化学品市场：2022 年和 2032 年应用收入趋势分析
    • 药物开发
    • 疫苗生产
    • 疗法
    • 细胞株开发
    • 农业
    • 食品和饮料
    • 其他的

第 8 章：全球重组化学品市场规模与预测：按地区 - 2022-2032

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第 9 章：竞争情报

  • 重点企业SWOT分析
  • 顶级市场策略
  • 公司简介
    • Genentech, Inc.
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 市场策略
    • Amgen Inc.
    • Biogen
    • Pfizer, Inc.
    • Novartis AG
    • Merck & Co.
    • Sanofi
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson Services, Inc.
    • Bayer AG
    • Mitsubishi Chemical Group
    • Bharat Serums and Vaccines (BSV)
    • Serum Institute of India
    • University of Sao Paulo (USP)
    • Oswaldo Cruz Foundation (FIOCRUZ)

第 10 章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性
简介目录

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032. Recombinant chemicals, produced through genetic engineering techniques, include recombinant proteins, DNAs, and peptides. Recombinant proteins are polypeptides produced from cloned genes and are widely employed in fields such as medicine, research, and biotechnology due to their advantages such as high purity, specificity, efficiency, safety, customization, scalability, and consistency. Recombinant proteins are used in vaccine development, therapeutics, diagnostics, and drug discovery and development. They include cytokines, enzymes, hormones, blood clotting factors, growth factors, monoclonal antibodies (mAbs), and antibody-related products. Recombinant protein vaccines are considered safer than vaccines derived from live viruses as they are non-replicating and lack infectious components.

The rise in demand for recombinant protein vaccines is significantly driving the market value of recombinant chemicals. Recombinant protein vaccines, which constitute a proven and well-established vaccine development platform, are particularly in demand due to the increased need for recombinant protein-based SARS-CoV-2 vaccines, thereby augmenting the demand for DNA-derived chemicals. The prevalence of genetic disorders is also fueling the recombinant chemicals market development. Medicinal products produced through recombinant DNA technology have revolutionized the treatment and management of various genetic disorders. Key players operating in the recombinant chemicals market are producing high-purity recombinant products for studying antibody and enzyme binding sites, as well as novel small therapeutics, drug agents, and vaccines.

Recombinant DNA technology, which involves the joining of DNA molecules from two different species, is gaining traction in the production of pharmaceutical and biotechnological products, including nutraceuticals. Products such as Elelyso, which contains the active substance taliglucerase alfa, are produced using recombinant DNA technology for the treatment of genetic disorders like type 1 Gaucher disease.

Key regions considered for the global Recombinant Chemicals Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. In 2023, North America stands out as the dominating region. This dominance is primarily driven by the presence of advanced biotechnology infrastructure, significant investments in research and development, and the presence of major pharmaceutical and biotech companies. Additionally, strong support from government initiatives and a high demand for biopharmaceuticals contribute to North America's leading position in this market. On the other hand, the Asia-Pacific region is the fastest-growing market for recombinant chemicals. The rapid growth in this region is fueled by increasing healthcare expenditures, a growing biotech industry, and rising investments in life sciences research. Countries like China and India are at the forefront of this growth due to their expanding pharmaceutical sectors, favorable government policies, and a rising focus on precision medicine. Additionally, the availability of a skilled workforce and the establishment of new biotech startups further accelerate the market expansion in the Asia-Pacific region.

Major market players included in this report are:

  • Genentech, Inc.
  • Amgen Inc.
  • Biogen
  • Pfizer, Inc.
  • Novartis AG
  • Merck & Co.
  • Sanofi
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Mitsubishi Chemical Group
  • Bharat Serums and Vaccines (BSV)
  • Serum Institute of India
  • University of Sao Paulo (USP)
  • Oswaldo Cruz Foundation (FIOCRUZ)

The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Recombinant Proteins
  • Recombinant DNAs
  • Recombinant Peptides
  • Others

By Technology:

  • Microbial Expression Systems
  • Mammalian Cell Expression Systems
  • Yeast Expression Systems
  • Insect Cell Expression Systems
  • Cell-free Expression Systems

By Application:

  • Drug Development
  • Vaccine Production
  • Therapeutics
  • Cell Line Development
  • Agriculture
  • Food and Beverage
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2034

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Recombinant Chemicals Market Executive Summary

  • 1.1. Global Recombinant Chemicals Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By Technology
    • 1.3.3. By Application
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Recombinant Chemicals Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Recombinant Chemicals Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rise in Demand for Recombinant Protein Vaccines
    • 3.1.2. Surge in Prevalence of Genetic Disorders
  • 3.2. Market Challenges
    • 3.2.1. Economic Uncertainty and Cost Concerns
  • 3.3. Market Opportunities
    • 3.3.1. Innovations in Recombinant DNA Technology
    • 3.3.2. Expansion of Application Areas

Chapter 4. Global Recombinant Chemicals Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Recombinant Chemicals Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Recombinant Chemicals Market: Product Type Revenue Trend Analysis, 2022 & 2032(USD Billion)
    • 5.2.1. Recombinant Proteins
    • 5.2.2. Recombinant DNAs
    • 5.2.3. Recombinant Peptides
    • 5.2.4. Others

Chapter 6. Global Recombinant Chemicals Market Size & Forecasts by Technology 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Recombinant Chemicals Market: Technology Revenue Trend Analysis, 2022 & 2032(USD Billion)
    • 6.2.1. Microbial Expression Systems
    • 6.2.2. Mammalian Cell Expression Systems
    • 6.2.3. Yeast Expression Systems
    • 6.2.4. Insect Cell Expression Systems
    • 6.2.5. Cell-free Expression Systems

Chapter 7. Global Recombinant Chemicals Market Size & Forecasts by Application 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Recombinant Chemicals Market: Application Revenue Trend Analysis, 2022 & 2032(USD Billion)
    • 7.2.1. Drug Development
    • 7.2.2. Vaccine Production
    • 7.2.3. Therapeutics
    • 7.2.4. Cell Line Development
    • 7.2.5. Agriculture
    • 7.2.6. Food and Beverage
    • 7.2.7. Others

Chapter 8. Global Recombinant Chemicals Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Recombinant Chemicals Market
    • 8.1.1. U.S. Recombinant Chemicals Market
      • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Technology breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Recombinant Chemicals Market
  • 8.2. Europe Recombinant Chemicals Market
    • 8.2.1. UK Recombinant Chemicals Market
    • 8.2.2. Germany Recombinant Chemicals Market
    • 8.2.3. France Recombinant Chemicals Market
    • 8.2.4. Spain Recombinant Chemicals Market
    • 8.2.5. Italy Recombinant Chemicals Market
    • 8.2.6. Rest of Europe Recombinant Chemicals Market
  • 8.3. Asia-Pacific Recombinant Chemicals Market
    • 8.3.1. China Recombinant Chemicals Market
    • 8.3.2. India Recombinant Chemicals Market
    • 8.3.3. Japan Recombinant Chemicals Market
    • 8.3.4. Australia Recombinant Chemicals Market
    • 8.3.5. South Korea Recombinant Chemicals Market
    • 8.3.6. Rest of Asia Pacific Recombinant Chemicals Market
  • 8.4. Latin America Recombinant Chemicals Market
    • 8.4.1. Brazil Recombinant Chemicals Market
    • 8.4.2. Mexico Recombinant Chemicals Market
    • 8.4.3. Rest of Latin America Recombinant Chemicals Market
  • 8.5. Middle East & Africa Recombinant Chemicals Market
    • 8.5.1. Saudi Arabia Recombinant Chemicals Market
    • 8.5.2. South Africa Recombinant Chemicals Market
    • 8.5.3. Rest of Middle East & Africa Recombinant Chemicals Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Genentech, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Amgen Inc.
    • 9.3.3. Biogen
    • 9.3.4. Pfizer, Inc.
    • 9.3.5. Novartis AG
    • 9.3.6. Merck & Co.
    • 9.3.7. Sanofi
    • 9.3.8. F. Hoffmann-La Roche AG
    • 9.3.9. Johnson & Johnson Services, Inc.
    • 9.3.10. Bayer AG
    • 9.3.11. Mitsubishi Chemical Group
    • 9.3.12. Bharat Serums and Vaccines (BSV)
    • 9.3.12. Serum Institute of India
    • 9.3.14. University of Sao Paulo (USP)
    • 9.3.15. Oswaldo Cruz Foundation (FIOCRUZ)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes